Start-Up Previews (09/00)
Executive SummaryA preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, New Approaches to Neurodegenerative Disorders, features profiles of Active Pass Pharmaceuticals Inc., Aegera Therapeutics Inc., Panacea Pharmaceuticals Inc. and Proteotech Inc. Plus these selected Start-Ups across Health Care: Amicas Inc., CFY Biomedicals Inc., MDISource and Visco Technologies Inc.
You may also be interested in...
GNC hires Josh Burris as chief US officer; Clasado BioSciences adds Bellchambers as commercial director; and Barentz plans expansion with Cinven investment.
The House passage of a Democratic bill authorizing the federal government to negotiate drug prices in Medicare has sharpened the debate over how prices feed innovation, but the underlying policy stands little chance of being enacted without a Democratic wave in the next election. Pink Sheet's table highlights the key provisions of HR 3 and other pending pricing legislation.